Scholarlink

<p>The IDEAL stage 1/2a study demonstrated feasibility of the use of the Versius robotic platform at a single institution. This multi-center collaborative modified stage 2b study adds wider exploration assessing surgical, oncologic and functional outcomes in patients undergoing urological procedures with the Versius. Data were collected from a prospective registry. Surgical outcomes were cross-checked from electronic patient records held at each hospital included in the study. All UK-based centers performing urological procedures using the Versius robot. All patients who underwent a robotic procedure using the Versius robot since inception to Jan 2023. Five UK hospitals have undertaken a total of 70 urological procedures using the Versius (Table&#xa0;<InternalRef RefID="Tab1">1</InternalRef>). Device failure occurred in one of the cases requiring conversion to laparoscopy and a further case required conversion to open due to intra-operative complication (2/70, 2.9%). One positive margin was observed in a robotic prostatectomy patient (12.5%). Immediate continence was achieved in 4 of 8 (50%) after prostatectomy. Eight patients (11.4%) had complications within 30&#xa0;days, and three were Clavien–Dindo class 3 and one class 4. A range of urological procedures were shown to be feasible and safe using the Versius across multiple sites.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A registry-based modified IDEAL stage 2b evaluation of urological procedures performed using the versius robotic surgical system

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月26日

查看全文
  • Ata Jaffer,
  • Daniel Chia,
  • Sonpreet Rai,
  • Sachin Veer,
  • Kevin Gallagher,
  • Mohammed Aldiwani,
  • Muddassar Hussain,
  • Sohail Nakhuda,
  • Farleigh Reeves,
  • Abhay Rane,
  • Sebastian Ourselin,
  • Alan McNeill,
  • Ben Challacombe,
  • Prokar Dasgupta

摘要

The IDEAL stage 1/2a study demonstrated feasibility of the use of the Versius robotic platform at a single institution. This multi-center collaborative modified stage 2b study adds wider exploration assessing surgical, oncologic and functional outcomes in patients undergoing urological procedures with the Versius. Data were collected from a prospective registry. Surgical outcomes were cross-checked from electronic patient records held at each hospital included in the study. All UK-based centers performing urological procedures using the Versius robot. All patients who underwent a robotic procedure using the Versius robot since inception to Jan 2023. Five UK hospitals have undertaken a total of 70 urological procedures using the Versius (Table 1). Device failure occurred in one of the cases requiring conversion to laparoscopy and a further case required conversion to open due to intra-operative complication (2/70, 2.9%). One positive margin was observed in a robotic prostatectomy patient (12.5%). Immediate continence was achieved in 4 of 8 (50%) after prostatectomy. Eight patients (11.4%) had complications within 30 days, and three were Clavien–Dindo class 3 and one class 4. A range of urological procedures were shown to be feasible and safe using the Versius across multiple sites.